Changes in serum bile acid levels associated with bezafibrate add-on therapy in patients with primary biliary cholangitis and inadequate biochemical response to ursodeoxycholic acid: results from the BEZURSO trial (NCT01654731) - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Hepatology Année : 2017

Changes in serum bile acid levels associated with bezafibrate add-on therapy in patients with primary biliary cholangitis and inadequate biochemical response to ursodeoxycholic acid: results from the BEZURSO trial (NCT01654731)

(1) , (2) , (3) , (4) , (5) , (6, 7) , (8) , (9) , (10) , , (11) , (12, 13) , (14, 15) , (16) , (17) , (18) , (19, 20) , (21) , (22) , (23) , (24, 25, 26) , (27) , , (28) , (29) , (4) , (29, 4) , (3)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
Minello Anne
  • Fonction : Auteur
Christine Silvain
Jean-Pierre H. Zarski
  • Fonction : Auteur
Tabassome Simon
Fichier non déposé

Dates et versions

hal-03590928 , version 1 (28-02-2022)

Identifiants

  • HAL Id : hal-03590928 , version 1

Citer

Christophe Corpechot, Olivier Chazouilleres, Lydie Humbert, Alexandra Rousseau, Antonia Le Gruyer, et al.. Changes in serum bile acid levels associated with bezafibrate add-on therapy in patients with primary biliary cholangitis and inadequate biochemical response to ursodeoxycholic acid: results from the BEZURSO trial (NCT01654731). Hepatology, 2017, 66 (1, SI), pp.168A. ⟨hal-03590928⟩
19 Consultations
0 Téléchargements

Partager

Gmail Facebook Twitter LinkedIn More